Differential inhibitory mechanism of cyclic AMP on TNF‐α and IL‐12 synthesis by macrophages exposed to microbial stimuli
Open Access
- 1 July 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (5) , 1195-1205
- https://doi.org/10.1038/sj.bjp.0702624
Abstract
Microbial stimuli such as bacterial lipopolysaccharide (LPS) or glycosylphosphatidylinositol‐mucins derived from Trypanosoma cruzi trypomastigotes (tGPI‐mucins) are effective stimulators of the synthesis of cytokines by macrophages. Here, we evaluated the ability of cyclic AMP mimetic or elevating agents to modulate TNF‐α and IL‐12 synthesis by murine inflammatory macrophages. Cholera Toxin (ChTx) inhibited tGPI‐mucins (2.5 nM) or LPS (100 ng ml−1) induced TNF‐α and IL‐12(p40) synthesis in a concentration‐dependent manner. Similarly, the cyclic AMP mimetics, 8‐bromo cyclic AMP or dibutyryl cyclic AMP, or prostaglandin (PG) E2 inhibited the synthesis of both cytokines by macrophages exposed to microbial stimuli. The protein kinase A inhibitor H‐89 partially reversed the inhibitory effects of dibutyryl cyclic AMP and PGE2 on both IL‐12(p40) and TNF‐α synthesis. Pretreatment of macrophages with dibutyryl cyclic AMP or ChTx augmented the synthesis of IL‐10 triggered by microbial products. Elevation of cyclic AMP inhibited the synthesis of TNF‐α, but not IL‐12(p40), by inflammatory macrophages from IL‐10 knockout mice. Kinetic studies showed that synthesis of both TNF‐α and IL‐10 peaked at 8 h and IL‐12 at 24 h after stimulation with microbial stimuli. Together, our findings favour the hypothesis that the cyclic AMP inhibitory activity on IL‐12(p40) but not on TNF‐α synthesis is dependent on de novo protein synthesis, most likely involving IL‐10, by macrophages stimulated with microbial products. Accordingly, dibutyryl cyclic AMP inhibited IL‐12(p40) synthesis only when added before or at the same time of the stimuli. In contrast, the effect of this cyclic AMP analogue on TNF‐α synthesis was protracted and observed even 2 h after the addition of the stimuli. British Journal of Pharmacology (1999) 127, 1195–1205; doi:10.1038/sj.bjp.0702624Keywords
This publication has 53 references indexed in Scilit:
- Differential regulation of IFN‐γ, IL‐10 and inducible nitric oxide synthase in human T cells by cyclic AMP‐dependent signal transduction pathwayImmunology, 1997
- Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in miceEuropean Journal of Immunology, 1995
- Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.The Journal of Experimental Medicine, 1995
- Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production.The Journal of Experimental Medicine, 1995
- Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.The Journal of Experimental Medicine, 1995
- Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.The Journal of Experimental Medicine, 1994
- Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction.The Journal of Experimental Medicine, 1994
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- IL-12: Initiation Cytokine for Cell-Mediated ImmunityScience, 1993
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.The Journal of Experimental Medicine, 1989